VMP 41952011000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Metronidazole 200mg/5ml oral suspension
BNF code 0501110C0AAAEAE
Virtual Therapeutic Moiety Metronidazole
Date identifier became valid 9 Jun 2023
Previous product identifier 324520007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure spoonful
Virtual Product Ingredient
Ingredient Metronidazole benzoate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372602008
Strength value numerator 40.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Oral suspension
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Metronidazole 200mg/5ml oral suspension (A A H Pharmaceuticals Ltd)
Metronidazole 200mg/5ml oral suspension (Alliance Healthcare (Distribution) Ltd)
Metronidazole 200mg/5ml oral suspension (CST Pharma Ltd)
Metronidazole 200mg/5ml oral suspension (Dawa Ltd)
Metronidazole 200mg/5ml oral suspension (Medihealth (Northern) Ltd)
Metronidazole 200mg/5ml oral suspension (Morningside Healthcare Ltd)
Metronidazole 200mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd)
Metronidazole 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc)
Metronidazole 200mg/5ml oral suspension (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Metronidazole 200mg/5ml oral suspension 100 ml

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback